Inspira Technologies OXY B.H.N. Ltd. has announced a strategic expansion of its blood laboratory capabilities, moving to a larger, state-of-the-art facility. The upgrade aims to increase sample processing capacity and integrate advanced technologies for blood-based diagnostics. The company plans to hire specialized personnel and add engineers and data-science experts to enhance operational capabilities. This move positions Inspira for accelerated growth in meeting high-value medical needs. The expansion will support the development of advanced diagnostic technologies for long-term patient and shareholder value. The company will provide further updates as the new laboratory becomes fully operational.

Read more at GlobeNewswire: Inspira Technologies Announces Strategic Leap in Lab